医药+金融+大健康

Search documents
吉林敖东药业集团股份有限公司 2025年半年度业绩预告
Zheng Quan Ri Bao· 2025-07-11 22:30
Group 1 - The company expects a positive net profit for the period from January 1, 2025, to June 30, 2025, indicating a significant improvement in performance [1] - The company has communicated with its accounting firm regarding the earnings forecast, and there are no disagreements on the forecast [1][2] - The substantial growth in performance is attributed to increased fair value changes and investment income, with non-recurring gains expected to positively impact net profit by approximately 114.50 million yuan, compared to a loss of 274.77 million yuan in the same period of 2024 [2]